Cost-Effectiveness Analysis of Neoadjuvant Chemotherapy With Zoledronic Acid for HER2-Negative Breast Cancer in Japan: The JONIE1 Study
Health
doi 10.4236/health.2019.118080
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2019
Authors
Publisher
Scientific Research Publishing, Inc.